Earnings Volatility Drives These Stocks in a New Direction

BIOLASE Inc (NASDAQ:BIOL) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.06 in the quarter versus EPS of $-0.05 in the year-earlier quarter. Revenue Rose 18.51% to $14.6 million from the year-earlier quarter.

reported adjusted EPS loss of $0.06 per share. By that measure, the company missed the mean analyst estimate of $-0.02. It beat the average revenue estimate of $14.48 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

BIOL

SurModics Inc. (NASDAQ:SRDX) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 42.86% to $0.20 in the quarter versus EPS of $0.14 in the year-earlier quarter. Revenue Rose 12.2% to $13.7 million from the year-earlier quarter.

SurModics Inc. reported adjusted EPS income of $0.20 per share. By that measure, the company missed the mean analyst estimate of $0.21. It missed the average revenue estimate of $13.92 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

SRDX

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) had a loss and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.03 in the quarter versus EPS of $-0.13 in the year-earlier quarter. Revenue Was the same at $7 million as the year-earlier quarter.

Keryx Biopharmaceuticals Inc. reported adjusted EPS loss of $0.03 per share. By that measure, the company missed the mean analyst estimate of $-0.01. It beat the average revenue estimate of $5.83 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

KERX

Codexis, Inc. (NASDAQ:CDXS) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.25 in the quarter versus EPS of $-0.21 in the year-earlier quarter. Revenue Decreased 63.13% to $11.48 million from the year-earlier quarter.

Codexis, Inc. reported adjusted EPS loss of $0.25 per share. By that measure, the company beat the mean analyst estimate of $-0.35. It beat the average revenue estimate of $7.63 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

CDXS

Exelixis, Inc. (NASDAQ:EXEL) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.24 in the quarter versus EPS of $-0.18 in the year-earlier quarter. Revenue Decreased 47.6% to $9.7 million from the year-earlier quarter.

Exelixis, Inc. reported adjusted EPS loss of $0.24 per share. By that measure, the company beat the mean analyst estimate of $-0.28. It beat the average revenue estimate of $5.33 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

EXEL

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:   , , ,  

More from The Cheat Sheet